Abstract: An injectable pharmaceutical composition for veterinary use is disclosed comprising Florfenicol, N-methyl-2-pyrrolidone, polyethylene glycol and a viscosity reducing agent. The composition is chemically and physically stable, exhibits constant blood levels and does not product undesirable side effects.
Type:
Grant
Filed:
August 29, 1990
Date of Patent:
January 21, 1992
Assignee:
Schering Corporation
Inventors:
Henry M. Apelian, David Coffin-Beach, Abu S. Huq
Abstract: 4-Phenyl-1,2,3,4-tetrahydro-1-napthalenamine derivatives have been found useful for the treatment of psychosis, inflammation and as immunosuppressants.